Aerial Pharma

Aerial BioPharma is a clinical-stage biopharmaceutical company based in Morrisville, North Carolina, focused on the development of novel therapies for central nervous system (CNS) disorders. The company was founded in 2011 by the experienced management team behind Addrenex Pharmaceuticals, which was previously acquired by Shionogi. Aerial's business model centers on identifying high-potential, early-stage assets and advancing them through clinical proof-of-concept. Their most notable success is the development of solriamfetol (Sunosi), a dopamine and norepinephrine reuptake inhibitor for excessive daytime sleepiness, which was sold to Jazz Pharmaceuticals in a significant deal. Today, the company continues to evaluate and develop new candidates within the neurology and sleep medicine space.